Search

Some of you may recall that, last year, I put out a call to contribute to a special issue of Pharmaceuticals on “Bacteriophages as Therapeutic Delivery Vehicles.” We have 10 articles published or near completion already but there’s room fo

This week, we're highlighting the three feature articles we published in May: a 'behind-the-paper' guest post by Steven Sutcliffe and Michael Shamash, a full recap of all six iVoM webinars by Ivone Martins and Luis Melo, and an interview wi

Colin Hill's Gut Phageomics Lab at APC Microbiome in Cork, Ireland is seeking a wet-lab/bioinformatics postdoc and wet-lab research assistant to investigate the role of phages in health and disease.

The Buchan lab within the Department of Microbiology at the University of Tennessee is seeking a post-doctoral research associate to study phages that infect a member of the Roseobacter lineage of marine bacteria. Please feel free to contac

Felix Biotechnology is hiring an Intern! As a Felix intern, you'll support Felix's efforts in developing phage therapeutics using techniques such as bacterial culture, phage/host interaction studies, and microbial genetic engineering. Conta

PHAVES #18 will be a seminar by Rob McBride, co-founder of Felix Biotechnology, on Tues, June 8, 5PM Pacific time. Rob will give a talk on 'Using machine learning to design phages with enhanced therapeutic features'. Small group networking

The African Phage Forum (APF) hosted its third and fourth events in April and May — thanks to all those who attended! APF 3: Dr. Jesca Nakavuma, Veterinarian, Senior Lecturer, Microbiologist, and Former Deputy Principal of the College of V

PHAVES #18 will be a seminar by Rob McBride, co-founder of Felix Biotechnology, on Tues, June 8, 5PM Pacific time. Rob will give a talk on 'Using machine learning to design phages with enhanced therapeutic features'. Small group networking

The Australian Society for Microbiology annual conference is approaching fast — next week to be exact! (May 31-June 3). Excitingly, the program features lots of phage talks! This is a hybrid event, and will run both in-person and online. Re

PhageSuisse will host its third webinar on June 1st at 19h00, entitled "phageSuisse meets industry" with Dr. Frenk Smrekar from JAFRAL and Dr. Lorenzo Corsini from PhagoMed.

The International Virus Bioinformatics Meeting 2022 (ViBioM 2022) will be held in Valencia, Spain, 24–25 March 2022. The meeting (currently planned to be in-person) is jointly organized by the European Virus Bioinformatics Center (EVBC), th

Wondering whether collecting and studying phages is worth your while? Here's a new article in Cystic Fibrosis News Today that remembers Mallory Smith, a young woman who phages could have saved, if they'd only been accessible a few days earl

Carlos Guerrero-Bustamante (University of Pittsburgh) and colleagues published a new paper in MBio showing their progress toward developing a phage cocktail for tuberculosis; using genome engineering and phage genetics, they have created a

Graça Pinto (University of Minho) and colleagues published a new paper in BMC Genomics showing insights into the genome architecture and evolution of Shiga toxin encoding phages of E. coli.

Tristan Ferry (Hospices Civils de Lyon) and colleagues published a new case report in Frontiers in Medicine describing the combination of arthroscopic “Debridement Antibiotics and Implant Retention” (DAIR) with local injection of personaliz

Shakhinur Islam Mondal (APC Microbiome Ireland) and colleagues published a new paper in International Journal of Molecular Sciences that characterizes a Clostridioides difficile-specific endolysin that affects spore outgrowth.

What brought phage therapy to where it is today? This week, we're featuring an interview with Dr. David Harper, CEO of Evolution Biotechnologies, by Curtis Hoffmann, a longtime Phage Directory volunteer. They discuss David's thoughts on his

Intralytix (Columbia, Maryland) is currently seeking an experienced Research Scientist for a hands-on bench-based position to participate in various research projects focused on the development of bacteriophage-based products.

The Frunzke lab (Forschungszentrum Jülich, Germany) is currently looking for a new PhD student to work on novel antiphage defense strategies in Streptomyces.

Eligo Bioscience (Paris, France) is looking for a Research Scientist to strategically construct and characterize bacterial and phage collections that are associated with a wide range of diseases and then develop synthetic biology tools for